Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Prostatic Neoplasms 9Neoplasms 9Lung Neoplasms 6Endometrial Neoplasms 6Breast Neoplasms 6Stomach Neoplasms 4Oropharyngeal Neoplasms 4Melanoma 4Colorectal Neoplasms 4Pathologic Complete Response 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Mouth Neoplasms 3Leukemia, Myeloid, Acute 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rectal Neoplasms 2Meningioma 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leiomyoma 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Hepatocellular 2Carcinoma, Basal Cell 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Trauma, Nervous System 1

Interventions

Cyclophosphamide 43venetoclax 30Cytarabine 25fludarabine 22fludarabine phosphate 17Azacitidine 16Mycophenolic Acid 13Whole-Body Irradiation 12Dexamethasone 12Rituximab 11Busulfan 11ruxolitinib 10Vincristine 10Methotrexate 10Etoposide 10Tacrolimus 9Mercaptopurine 9Daunorubicin 9Prednisone 8Filgrastim 8Dasatinib 8ibrutinib 7Peripheral Blood Stem Cell Transplantation 7Melphalan 7Granulocyte Colony-Stimulating Factor 7Doxorubicin 7Decitabine 7pegaspargase 6blinatumomab 6Mesna 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Observation × 1 year × Clear all
NCT03059485 2026-02-04

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Beth Israel Deaconess Medical Center

Phase 2 Active not recruiting
82 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡